WELLINGTON MANAGEMENT GROUP LLP

Position in MGTX — MeiraGTx Holdings plc

CIK 902219 Boston, MA

Position in MGTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,094,025

+$55,676 QoQ

Shares Held

126,331

-3.3% QoQ

Ownership

0.136%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 70.58125084104456.ToString("F0")% None 29.418749158955443.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,771 across 180 Biotechnology names. MGTX ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,094,025	126,331	-3.3%	Shares	Defined	2026-05-15
2025-12-31	$1,038,349	130,610	-7.8%	Shares	Defined	2026-02-17
2025-09-30	$1,166,486	141,736	-36.3%	Shares	Defined	2025-11-14
2025-06-30	$1,450,184	222,421	+7.5%	Shares	Defined	2025-08-14
2025-03-31	$1,403,324	206,980	+37.0%	Shares	Defined	2025-05-13
2024-12-31	$920,356	151,126	+0.9%	Shares	Defined	2025-02-12
2024-09-30	$624,444	149,747	-11.4%	Shares	Defined	2024-11-14
2024-06-30	$711,738	169,059	+12.7%	Shares	Defined	2024-08-14
2024-03-31	$910,262	149,961	+2.4%	Shares	Defined	2024-05-15
2023-12-31	$1,028,121	146,456	—	Shares	Defined	2024-02-12
No filing history on record for this holder in this stock.